^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

sequential different B cell antigen-targeted CAR T-cell therapy

i
Other names: sequential different B cell antigen-targeted CAR T-cell therapy, sequentialB antigen chimeric antigen receptor T cells
Associations
Trials
Company:
Beijing Boren Hospital
Drug class:
CD19-targeted CAR-T immunotherapy, CD20-targeted CAR-T immunotherapy, CD22-targeted CAR-T immunotherapy
Related drugs:
Associations
Trials